Updated on 17 July 2012
Pall Life Sciences is one of the pioneers of single-use technology. "Pall's Allegro single-use platform provides single-use processing solutions, technical support and validation services. With consistent material of construction, the small- to large-scale single-use systems are ideal for scaling up or scaling down processes, and incorporating technologies such as biocontainers, sterile connectors, sterile filtration, virus filtration, chromatography and tangential flow filtration. The philosophy of single-use is now an integral part of the industry and is changing the way in which manufacturers look at their production processes," says Mr Stefan Egli, president, Pall Life Sciences Asia, Singapore.
GE Healthcare has gained capacity to build low-cost, flexible, good manufacturing practices vaccine-manufacturing facility with easy-to-operate, single-use bioprocessing technologies equipped to grow cell lines up to 1,000 liters.
Xcellerex, a supplier of innovative manufacturing technologies for the fast-growing biopharmaceutical industry, has recently introduced XDR-10 single-use bioreactor designed for bench top use. The XDR-10 allows scale-up to full production and is ideal for GMP clinical and commercial manufacturing of biotherapeutics, vaccines, and other biologics. Similarly, Merck Millipore has introduced Mobius CellReady 50 L bioreactor that extends the company's portfolio of single-use processing systems from cell culture to ultrafiltration and diafiltration. The innovative Mobius SensorReady technology offers flexibility to configure process monitoring at the point of use, reducing the need to customize bioreactor process containers and enables easy integration of new sensor technologies.